Contract 75N91022C00060
Amplifidx Inc · Department Of Health And Human Services · September 10, 2024
Amplifidx Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on September 10, 2024 for $400,000 (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in San Francisco, CA. It was awarded under a small business set-aside. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $400,000.
Contract details
- PIID
- 75N91022C00060
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- Small Business Set Aside - Total
- Competition
- Full And Open Competition After Exclusion Of Sources
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- San Francisco, CA
- First action
- September 10, 2024
Description
PHS 2022-1 TOPIC 440 - CANCER PREVENTION & DIAGNOSIS TECHNOLOGIES FOR LOW-RESOURCE SETTINGS
Modification timeline
-
September 10, 2024Mod P00004 · Supplemental Agreement For Work Within Scope$400.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91022C00060?
Contract 75N91022C00060 is a federal contract awarded to Amplifidx Inc by Department Of Health And Human Services on September 10, 2024 for $400,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N91022C00060?
Amplifidx Inc won contract 75N91022C00060 from Department Of Health And Human Services.
How much is contract 75N91022C00060 worth?
Contract 75N91022C00060 has obligated $0 to date but carries a potential ceiling of $400,000 if fully funded and all options are exercised.